![Seng Chin Mah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seng Chin Mah
Vorsitzender bei
BIOVERSYS AG
Vermögen: 3 Mio $ am 31.07.2026
Profil
Seng Chin Mah is currently Chairman at BioVersys AG since 2009 and Independent Director at OSR Health, Inc. starting in 2025.
Formerly, Dr. Mah was Chief Executive Officer at Canyon Pharmaceuticals, Inc. and Canyon Pharmaceuticals Group AG from 2009 to 2021, and Director at Novartis Europharm Ltd. from 1997 to 2005.
Education includes an undergraduate degree from the University of London in 1984 and a doctorate from the University of Basel in 1987.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOVERSYS AG 1.31% | 31.12.2025 | 76’358 ( 1.31% ) | 3 Mio $ | 31.07.2026 |
Aktive Positionen von Seng Chin Mah
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOVERSYS AG | Vorsitzender | 01.01.2009 |
Ehemalige bekannte Positionen von Seng Chin Mah
| Unternehmen | Position | Ende |
|---|---|---|
Canyon Pharmaceuticals, Inc.
 Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Vorstandsvorsitzender | 01.01.2021 |
Canyon Pharmaceuticals Group AG
 Canyon Pharmaceuticals Group AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceuticals company | Vorstandsvorsitzender | 01.01.2021 |
Novartis Europharm Ltd.
 Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Direktor/Vorstandsmitglied | 01.01.2005 |
Ausbildung von Seng Chin Mah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Canyon Pharmaceuticals, Inc.
Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canyon Pharmaceuticals Group AG
Canyon Pharmaceuticals Group AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceuticals company | Health Technology |
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Novartis Europharm Ltd.
Novartis Europharm Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
